Workflow
Deal
icon
Search documents
Club Offers Released on June 19, 2025
Prnewswire· 2025-06-19 12:02
TORONTO, June 19, 2025 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces the release of Club Offers for Club Members.Rigorously vetted and negotiated for us travel enthusiasts in Canada: $999 & UP—6-NIGHT ALL-INCLUSIVE CANCUN VACATION WITH FLIGHTSSet on a serene lagoon, this all-inclusive beach resort is perfect for diving, watersports and private yacht expeditions. Club Members save up to $400 on this offer. $109-$189—PEI HARBOURVIEW INN WITH BREAKFAST This waterfront Su ...
Trump Says Iran Should Have Made a Nuclear Deal Earlier | WSJ News
WSJ News· 2025-06-18 15:35
Have you been answered questions about uh whether you are moving closer or you believe the US is moving closer to striking Iranian nuclear facilities? Where's your mindset on that? Can't say that, right? You don't seriously think I'm going to answer that question. Will you strike the Iranian nuclear component? And what time exactly, sir? Sir, would you strike it? Would you please inform us so we can be there and watch? I mean, you don't know that I'm going to even do it. You You don't know. I may do it. I m ...
Shell: Continued Strategy Execution Should Close The Gap To U.S. Peers
Seeking Alpha· 2025-06-17 22:03
Group 1: Company Overview - Shell is an oil and gas supermajor with operations across the entire energy supply chain [1] - The company has made strategic moves to focus solely on being UK-headquartered and is shifting towards cleaner energy [1] Group 2: Investment Focus - The analysis emphasizes a focus on undervalued and disliked companies or industries with strong fundamentals and good cash flows [2] - Energy Transfer is highlighted as a company that was previously overlooked but has potential for substantial returns [2] - The investment strategy leans towards long-term value investing while also considering deal arbitrage opportunities [2]
高盛:中国医疗-从我们的全球医疗会议及美国市场投资者反馈中交叉解读
Goldman Sachs· 2025-06-17 06:17
16 June 2025 | 10:20PM HKT China Healthcare Read across from our global healthcare conference and investor feedback from US marketing We participated in the 46th Global Healthcare Conference (June 9-11) and met with 20+ US investors across Miami and New York. Discussions centered on the momentum behind China biotech's re-rating (+72% YTD, vs +17% for MXCN, see Exhibit 1), driven by a surge in licensing-out deals, particularly in PD-1/VEGF bispecifics, which validated asset quality and innovation. Investors ...
Hard to be positive about situation between Iran and Israel, says AEI's James Pethokoukis
CNBC Television· 2025-06-16 18:51
James Pakukus is economic policy analyst at the American Enterprise Institute and a CNBC contributor. It's good to have you here and I think that in some ways these stories are related because it was not it was just a couple of weeks ago we were told, you know, look, the US might be trying to strike a deal with Iran to bring those barrels back or keep them in the market even as it has to crack down on Russia. Well, now it sounds like um the tone is shifting towards more aggressive on both Iran and Russia.Ye ...
花旗:石油监测_持续的地缘政治紧张局势提供抛售 对冲机会
花旗· 2025-06-16 03:16
12 Jun 2025 15:07:47 ET │ 11 pages Oil Monitor Ongoing geopolitical tensions provide a selling/hedging opportunity V i e w p o i n t | CITI'S TAKE We are bearish on oil prices from current levels of $68-70/bbl Brent, expecting them to fall $60-65/bbl over the coming months, as oil fundamental pointing to a significant surplus during 2H'25, driven by OPEC+ returning its spare capacity to the market. We recommend producers take the opportunity to hedge into rallies related to any Israeli or US military action ...
摩根大通:中国生物科技-关于信达生物、康方生物和科伦博泰未来发展之路的思考
摩根· 2025-06-15 16:03
Asia Pacific Equity Research 12 June 2025 (852) 2800 8195 denise.yan@jpmorgan.com J.P. Morgan Securities (Asia Pacific) Limited/ J.P. Morgan Broking (Hong Kong) Limited J P M O R G A N Correction (first published 11 June 2025) (See disclosures for details) China Biotech Thoughts on the road ahead for Innovent, Akeso and Kelun-Biotech As we continue to receive questions on Innovent, Akeso and Kelun-Biotech during our marketing tour and in light of recent news flow on these three names, we offer some of our q ...
‘Makes Washington look feckless’: Experts slam U.S. response to Israel-Iran attacks
MSNBC· 2025-06-14 02:00
This makes Washington look pretty feckless, right? Because one of two things is true. Either Donald Trump did not want this to happen. Wanted Steve Wickoff to go there this weekend and Israel bombed Iran and killed the person that was overseeing those negotiations with Steve Wickoff. Or Donald Trump when he went to the Gulf Arabs a few weeks ago lied to them in saying that he won an Iran deal. Neither of those is a particularly good look for the United States. Either we're being duplicitous about matters as ...
Iran's back is against the wall, says Atlantic Council's Fred Kempe
CNBC Television· 2025-06-13 21:18
than a percent. Getting back near the recent all time highs. And that leads back to today's major geopolitical story.Those strikes and counter-strikes between Israel and Iran. The latest Israel's defense minister saying Iran crossed red lines with its strikes against Israeli cities. Joining me now is Fred Kempe, president and CEO of Atlantic Council and a CNBC contributor.Fred Israel's positioning this moment, it seems to be an existential threat to the Iranian regime. Is it. >> Look.>> We have someone work ...
Israel may need some ground operations to achieve its target, says Brookings' Mike O'Hanlon
CNBC Television· 2025-06-13 19:14
more hours left in this and much more to go before we know exactly what's going on. >> All right, Megan, thanks very much. Megan Cassella, let's turn now to Michael O'Hanlon.He's director of foreign policy research at the Brookings Institution. Michael. And so we are hearing from different analysts that they think this could actually be a rather drawn out affair.That's going to kind of put that on one side of the equation. On the other side, are those pointing out that the market reaction here is not outsiz ...